Literature DB >> 6143013

Not so benign long-term immunosuppression in multiple sclerosis?

F Lhermitte, R Marteau, E Roullet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6143013     DOI： 10.1016/s0140-6736(84)90145-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Chemotherapeutics in the treatment of multiple sclerosis.

Authors:  Bernd C Kieseier; Douglas R Jeffery
Journal:  Ther Adv Neurol Disord       Date:  2010-09       Impact factor: 6.570

Review 2.  Immunosuppressive agents in multiple sclerosis.

Authors:  Oliver Neuhaus; Bernd C Kieseier; Hans-Peter Hartung
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

3.  A double blind study on azathioprine efficacy in multiple sclerosis: final report.

Authors:  C Milanese; L La Mantia; A Salmaggi; M Eoli
Journal:  J Neurol       Date:  1993-05       Impact factor: 4.849

Review 4.  Role of immunosuppressive therapy for the treatment of multiple sclerosis.

Authors:  James M Stankiewicz; Hadar Kolb; Arnon Karni; Howard L Weiner
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

5.  Comparison of interferon beta products and azathioprine in the treatment of relapsing-remitting multiple sclerosis.

Authors:  M Etemadifar; M Janghorbani; V Shaygannejad
Journal:  J Neurol       Date:  2007-12-14       Impact factor: 4.849

6.  Risk factors for tumor occurrence in patients with myasthenia gravis.

Authors:  Antonietta Citterio; Ettore Beghi; Andrea Millul; Amelia Evoli; Renato Mantegazza; Carlo Antozzi; Fulvio Baggi; Ferdinando Cornelio; Luca Durelli; Marinella Clerico; Giovanni Piccolo; Vittorio Cosi
Journal:  J Neurol       Date:  2009-03-29       Impact factor: 4.849

7.  Evaluation of the risk of cervical cancer in patients with Multiple Sclerosis treated with cytotoxic agents: A cohort study.

Authors:  Rozita Doosti; Mansoureh Togha; Abdorreza Naser Moghadasi; Aida Aghsaie; Amir Reza Azimi; Saeideh Khorramnia; Zahra Moinfar; Fereshteh Ensani; Mohammad Hossein Harirchian; Alireza Minagar; Mohammad Ali Sahraian
Journal:  Iran J Neurol       Date:  2018-04-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.